Literature DB >> 6125203

Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.

M Mignon, N P Chau, B K Nguyen-Phuoc, M Sauvage, F Leguy, S Bonfils.   

Abstract

1 Ranitidine oral kinetics and plasma concentration-effect relationships upon meal-induced gastric secretion were investigated in normal subjects. Four oral doses of ranitidine (50, 100, 150 or 200 mg) and placebo were tested. 2 Oral ranitidine showed a terminal half-life of about 2 h 25 min. Maximal plasma level was about 240 ng/ml for a 100 mg dose, and occurred about 1 h after dose. From the range of 50 to 200 mg dose, no indication of non-linearity was observed in the drug kinetics. 3 Ranitidine administration resulted in a dose-related reduction in meal-stimulated acid secretion reaching, 46, 70, 82 and 92%, respectively. Mean ranitidine plasma concentrations producing 50 and 80% inhibition of acid secretion were 73 and 180 ng/ml, respectively, with great inter-individual variability. 150 and 200 mg ranitidine oral doses maintained IC50 for at least 4.5 and 5.5 h, respectively. Upon oral administration, ranitidine exerted no effect on gastric emptying of the meal but slightly decreased the gastrin response to the meal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125203      PMCID: PMC1427757          DOI: 10.1111/j.1365-2125.1982.tb01960.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

2.  Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.

Authors:  C T Richardson
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

Review 3.  Drug therapy: Cimetidine.

Authors:  W Finkelstein; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

4.  New clinical method for measuring the rate of gastric emptying: the double sampling test meal.

Authors:  J D George
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

5.  [Contribution of the radioimmunologic determination of gastrin in digestive pathology].

Authors:  J P Accary; S Bonfils
Journal:  Nouv Presse Med       Date:  1973-01-06

6.  Radioimmunoassay of gastrin.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1970-01       Impact factor: 22.682

7.  Safety of cimetidine.

Authors:  D M Kruss; A Littman
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  The effect of antral distension on acid secretion and plasma gastrin in duodenal ulcer patients.

Authors:  S Bergegardh; G Nilsson; L Olbe
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

9.  Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects.

Authors:  C T Richardson; J H Walsh; M I Hicks; J S Fordtran
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

10.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more
  9 in total

1.  A comparison of gastric emptying rate after cimetidine and ranitidine measured by applied potential tomography.

Authors:  M C Mushambi; T N Trotter; P Barker; D J Rowbotham
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

Review 3.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  Effect of painless rectal distension on gastrointestinal transit of solid meal.

Authors:  M S Youle; N W Read
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

Review 6.  Clinical pharmacokinetics of ranitidine.

Authors:  C J Roberts
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 7.  Interactions and non-interactions with ranitidine.

Authors:  W Kirch; H Hoensch; H D Janisch
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

8.  Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.

Authors:  R Parikh; J Sweetland; E R Forster; A W Bedding; S J Farr; J T Smith
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

9.  Pharmacokinetics of ranitidine in critically ill patients.

Authors:  K F Ilett; R L Nation; R Tjokrosetio; W R Thompson; T E Oh; P D Cameron
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.